MX359106B - Composicion farmaceutica inyectable de dexketoprofeno y tramadol. - Google Patents

Composicion farmaceutica inyectable de dexketoprofeno y tramadol.

Info

Publication number
MX359106B
MX359106B MX2014013083A MX2014013083A MX359106B MX 359106 B MX359106 B MX 359106B MX 2014013083 A MX2014013083 A MX 2014013083A MX 2014013083 A MX2014013083 A MX 2014013083A MX 359106 B MX359106 B MX 359106B
Authority
MX
Mexico
Prior art keywords
dexketoprofen
tramadol
pharmaceutical composition
injectable pharmaceutical
relates
Prior art date
Application number
MX2014013083A
Other languages
English (en)
Other versions
MX2014013083A (es
Inventor
Miguel Rizo Martínez José
Gómez Calvo Antonia
Sanz Menéndez Nuria
Muñoz Ruíz Ángel
Martinez Alzamora Fernando
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of MX2014013083A publication Critical patent/MX2014013083A/es
Publication of MX359106B publication Critical patent/MX359106B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica inyectable de dexketoprofeno y tramadol como principios activos. En particular, se trata de una solución de dexketoprofeno y tramadol en una mezcla de agua para inyección y al menos un cosolvente. La presente invención también se refiere a un procedimiento para la preparación de dicha composición, a una forma farmacéutica de dosificación unitaria que la contiene y a su uso para el tratamiento del dolor de intensidad moderado a severo, inflamación y/o fiebre.
MX2014013083A 2012-04-30 2013-04-29 Composicion farmaceutica inyectable de dexketoprofeno y tramadol. MX359106B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201200450A ES2432222B1 (es) 2012-04-30 2012-04-30 Composición farmacéutica inyectable de dexketoprofeno y tramadol
PCT/ES2013/000106 WO2013164498A1 (es) 2012-04-30 2013-04-29 Composición farmacéutica inyectable de dexketoprofeno y tramadol

Publications (2)

Publication Number Publication Date
MX2014013083A MX2014013083A (es) 2015-04-14
MX359106B true MX359106B (es) 2018-09-14

Family

ID=49514233

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013083A MX359106B (es) 2012-04-30 2013-04-29 Composicion farmaceutica inyectable de dexketoprofeno y tramadol.

Country Status (7)

Country Link
EP (1) EP2857016B1 (es)
BR (1) BR112014027002A2 (es)
CO (1) CO7170180A2 (es)
ES (1) ES2432222B1 (es)
MX (1) MX359106B (es)
RU (1) RU2660356C2 (es)
WO (1) WO2013164498A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3928766A1 (en) * 2020-06-26 2021-12-29 Usso Barnas Pharmaceutical composition and use thereof
EP4188337A1 (en) * 2020-07-31 2023-06-07 KRKA, d.d., Novo mesto Formulation containing dexketoprofen and tramadol and method for making the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1546478A (fr) 1967-01-27 1968-11-22 Rhone Poulenc Sa Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
CN1204891C (zh) * 2001-12-27 2005-06-08 沈阳药科大学 一种含有曲马多的注射液及其应用
US7090859B2 (en) * 2002-12-13 2006-08-15 Ronald Thomas Haas Ketoprofen compositions and methods of making them
MX2007013583A (es) * 2005-04-28 2008-03-13 Theraquest Biosciences Llc Metodos y composiciones para tratar el dolor.
BRPI0700133A (pt) 2007-01-29 2008-09-16 Incrementha P D & I Pesquisa D composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
WO2008150324A1 (en) * 2007-03-26 2008-12-11 Theraquest Biosciences, Inc. Subanalgesic doses of drug combinations

Also Published As

Publication number Publication date
MX2014013083A (es) 2015-04-14
CO7170180A2 (es) 2015-01-28
ES2432222A1 (es) 2013-12-02
RU2014148062A (ru) 2016-06-27
WO2013164498A1 (es) 2013-11-07
EP2857016B1 (en) 2017-02-22
EP2857016A4 (en) 2015-12-23
ES2432222B1 (es) 2014-06-10
EP2857016A1 (en) 2015-04-08
BR112014027002A2 (pt) 2017-06-27
RU2660356C2 (ru) 2018-07-05

Similar Documents

Publication Publication Date Title
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
NI201700073A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
GT201400043A (es) Imidazopiridazinas sustituidas con amino
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
CL2014001515A1 (es) Uso de dexmedetomidina o una sal de ella para tratar o prevenir el dolor sin sedacion importante tal como dolor idiopatico; y dispositivo de dosis medida que comprende una composicion farmaceutica con dexmedetomidina.
MX356827B (es) FORMULACION PARA ANTICUERPO ANTI-A4ß7.
CL2015002433A1 (es) Imidazopiridazinas sustituidas
MX2012005013A (es) Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel.
DOP2016000253A (es) Nuevos compuestos
CL2013001250A1 (es) Composicion intravenosa que contiene ibuprofeno y paracetamol combinados en dosis definidas; y uso en el tratamiento del dolor y/o inflamacion.
CL2015001869A1 (es) Composición inyectable acuosa de diclofenaco en una solucion de eter monoetilico de dietilenglicol y agua; metodo de preparacion; y uso en el tratamiento o prevencion del dolor y/o condiciones inflamatorias como dolor de cabeza, dolor de garganta, entre otras.
UY35848A (es) Tienopirimidinas
MX2017000764A (es) Formulacion acuosa que comprende paracetamol e ibuprofeno.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
NI201600006A (es) Pirazolo-piridinaminas sustituidas
NI201900063A (es) Amidas aromáticas de ácido carboxílico
CR20160432A (es) Inhibidores de las vías de señalización de wnt
MX359106B (es) Composicion farmaceutica inyectable de dexketoprofeno y tramadol.
ECSP15005163A (es) Composiciones líquidas orales pediátricas que contienen nepadutant
NI201200196A (es) Agentes terapéuticos 976
CL2015000778A1 (es) Composición farmacéutica oral sinérgica que comprende nitazoxanida y mebendazol; proceso de preparación; y uso para el tratar parasitosis humana provocada por protozoos y helmintos.
ES2422563A1 (es) Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma
EA201592261A1 (ru) Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой
CR20150411A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol
CO7240357A2 (es) Solución de acetaminofen supersaturada inyectable para la administración por la espina dorsal

Legal Events

Date Code Title Description
FG Grant or registration